Kert Sabbath

Kert Sabbath, MD, is an Associate Professor of Medicine (Medical Oncology) at Yale School of Medicine, specializing in breast and lung cancer treatment. He is affiliated with the Center for Breast Cancer and Center for Thoracic Cancers, and holds appointments in Medical Oncology and Hematology. His research focuses on clinical trials to provide cutting-edge care in community settings.

Education: MD from Boston University (1979), AB in Biology from Washington University in St. Louis (1975). Board certifications include Hematology, Medical Oncology, and Internal Medicine.

Research Interests: Clinical trials for breast and lung cancers, quality-of-life outcomes in oncology, and advancing treatments accessible to patients near their homes. Notable trials include studies on daratumumab regimens in multiple myeloma and nab-paclitaxel/carboplatin in NSCLC.

Recognition: Recipient of Connecticut Magazine Top Docs awards from 2015–2019, highlighting his clinical excellence.

Current Trials: Sub-investigator in trials for pembrolizumab/brentuximab vedotin, osimertinib/bevacizumab in lung cancer, and pancreatic neuroendocrine tumor treatments.

Labs/Teams: Active in Yale Cancer Center and collaborations with researchers like Tara Anderson and Elan Gorshein.